DJI46,429.49+0.66%
GDAXI22,957.08+1.41%
GSPC6,591.90+0.54%
HSI25,335.95+1.09%
IXIC21,929.83+0.77%
N22553,749.62+2.87%
AAPL252.62+0.39%
AMZN211.71+2.16%
CL91.29-1.15%
EURUSD1.1566-0.40%
GBPUSD1.3367-0.39%
GC4,503.30+2.30%
GOOG289.59+0.13%
JPM295.42+1.03%
META594.89+0.33%
MSFT371.04-0.46%
NVDA178.68+1.99%
TSLA385.95+0.76%
DJI46,429.49+0.66%
GDAXI22,957.08+1.41%
GSPC6,591.90+0.54%
HSI25,335.95+1.09%
IXIC21,929.83+0.77%
N22553,749.62+2.87%
AAPL252.62+0.39%
AMZN211.71+2.16%
CL91.29-1.15%
EURUSD1.1566-0.40%
GBPUSD1.3367-0.39%
GC4,503.30+2.30%
GOOG289.59+0.13%
JPM295.42+1.03%
META594.89+0.33%
MSFT371.04-0.46%
NVDA178.68+1.99%
TSLA385.95+0.76%
DJI46,429.49+0.66%
GDAXI22,957.08+1.41%
GSPC6,591.90+0.54%
HSI25,335.95+1.09%
IXIC21,929.83+0.77%
N22553,749.62+2.87%
AAPL252.62+0.39%
AMZN211.71+2.16%
CL91.29-1.15%
EURUSD1.1566-0.40%
GBPUSD1.3367-0.39%
GC4,503.30+2.30%
GOOG289.59+0.13%
JPM295.42+1.03%
META594.89+0.33%
MSFT371.04-0.46%
NVDA178.68+1.99%
TSLA385.95+0.76%
CYBERETIKAGLOBAL FINANCIAL INTELLIGENCE
LIVE
USA Seeking Alpha EN

Celcuity Non-GAAP EPS of -$0.73 beats by $0.28

Mar 25, 2026 &03052525202631; 20:05 UTC seekingalpha.com Trending 2/5
Read original on seekingalpha.com ↗
↗
Positive for markets
Sentiment score: +65/100
Low impact Short-term (days)
WHAT THIS MEANS
Celcuity reported non-GAAP EPS of -$0.73, beating expectations by $0.28—a significant positive surprise for a biotech company. However, this is a micro-cap stock with minimal market impact; the broader market context (S&P 500 +0.54%, VIX declining) suggests risk-on sentiment but no specific catalyst for CELC.
AI CONFIDENCE
52% Moderate
SENTIMENT GAUGE
NEWS POWER SCORE
AFFECTED ASSETS
⇅
CELC
CELCStock
High volatility expected
Positive EPS beat (+$0.28) is encouraging for a biotech, but micro-cap liquidity and lack of revenue/pipeline detail make directional conviction low. Market reaction will depend on guidance and institutional interest.
⇅
S&P 500
^GSPCIndex
High volatility expected
S&P 500 already up 0.54%; risk-on sentiment evident but no new catalyst from CELC earnings to drive further gains.
PRICE HISTORY
Loading chart...
⚡ SUGGESTED ACTION
CELC beat is real but confidence is low due to micro-cap status and lack of revenue/pipeline context. Skip unless you have deep biotech conviction or see institutional accumulation. The broader market is already pricing in risk-on sentiment. [MOVE:2.5%]
KEY SIGNALS
EPS beat by $0.28 (positive surprise)Non-GAAP metric (watch for GAAP reconciliation)Micro-cap biotech (low liquidity, high volatility)VIX declining (risk-on environment)
SECTORS INVOLVED
HealthcareBiotechnology
Analysis generated on Mar 25, 2026 at 20:10 UTC
Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Seeking Alpha. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

RELATED INTELLIGENCE

Boliden vinstvarnar – sänker helårsprognos
Dagens Industri Mar 25, 21:28 Negative
Lions Bay unit moves forward with Vantage assets bid after creditor meeting called
Seeking Alpha Mar 25, 21:18 Neutral
Bolidens resultat tyngs av produktionsstopp
Dagens Industri Mar 25, 21:09 Negative
Stock Market Today, March 25: Grab Dips After Announcing $400 Million Buyback and $600 Million Foodpanda Acquisition
The Motley Fool Mar 25, 21:01 Neutral
Equillium GAAP EPS of -$0.04 beats by $0.02, revenue of $0M
Seeking Alpha Mar 25, 20:59 Neutral